Found 33 matching trials
Low Dose Ticagrelor Versus Low Dose Prasugrel in Patients With Prior Myocardial Infarction PHASE4 Taken together the results from DAPT and PEGASUS-TIMI54, it appears that ph...
Show More Location
Attikon University Hospital
Learn More & Join Trial
Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study) PHASE4 Personalized treatment approaches and antiplatelet drug choice have been pr...
Show More Learn More & Join Trial
Impact of Antiretroviral Treatment on Pharmacokinetics and Pharmacodynamics of Thienopyridines in Healthy Volunteers and HIV Patients PHASE1 HIV patients are at particular risk to develop cardiovascular disease (CVD)...
Show More Location
University Hospitals
Learn More & Join Trial
P3AMI Antiplatelet Trial PHASE4 Major heart attacks are caused by a numerous factors, including sudden clot...
Show More Location
The Royal Wolverhampton NHS Trust
Learn More & Join Trial
The Role of the P2Y12 Receptor in Tissue Factor Induced Coagulation PHASE4 Severe sepsis still carries a high mortality rate despite advantages in int...
Show More Location
Medical University of Vienna, Department of Clinical Pharmacology
Learn More & Join Trial
Prasugrel Re-load Strategies PHASE4 A higher degree of platelet inhibition remains the goal of peri-interventio...
Show More Location
University of Florida
Learn More & Join Trial
High (100mg) Versus Standard (60mg) Loading Dose of Prasugrel in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI) PHASE3 This is a prospective, multi-center, non-randomized, controlled study in 2 ...
Show More Location
Dimitrios Alexopoulos
Learn More & Join Trial
De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS PHASE3 High bleeding risk (HBR) patients, comprising up to 50% of those presenting...
Show More Location
Azienda Ospedaliera Universitaria Gaetano Martino
Learn More & Join Trial
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia PHASE3 REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform tria...
Show More Location
University of Florida
Learn More & Join Trial
Platelet Aggregation and Adenosine Levels Among Patients Taking Ticagrelor or Prasugrel PHASE4 Prospective, single-center, double blind, double dummy, randomized trial. P...
Show More Location
Heart Institute (InCor) / University of São Paulo
Learn More & Join Trial